Percutaneous autologous bone marrow-derived mesenchymal stromal cell implantation is safe for reconstruction of human lower limb long bone atrophic nonunion
Cell Journal [Yakhteh]. 2017; 19 (1): 159-165
in English
| IMEMR
| ID: emr-185802
ABSTRACT
Objective:
Nonunion is defined as a minimum of a 9-month period of time since an injury with no visibly progressive signs of healing for 3 months. Recent studies show that application of mesenchymal stromal cells [MSCs] in the laboratory setting is effective for bone regeneration. Animal studies have shown that MSCs can be used to treat nonunions. For the first time in an Iranian population, the present study investigated the safety of MSC implantation to treat human lower limb long bone nonunion
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Transplantation, Autologous
/
Prospective Studies
/
Plastic Surgery Procedures
/
Lower Extremity
/
Mesenchymal Stem Cells
/
Autografts
Type of study:
Controlled clinical trial
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Language:
English
Journal:
Cell J. [Yakhteh]
Year:
2017
Similar
MEDLINE
...
LILACS
LIS